Sumitomo Pharma America

Sumitomo Pharma America (SMPA) is focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies.

Year Established: 2023 Stock Ticker: Exchange:

Locations